Nephros (NEPH) Invested Capital (2010 - 2022)

Nephros has reported Invested Capital for 9 years, with the latest figure at $9.1 million in Q4 2022.

• On a quarterly basis, Invested Capital fell 40.02% year-over-year to $9.1 million in Q4 2022; TTM through Dec 2022 was $9.1 million, a 40.02% decrease from a year earlier, with the FY2022 full-year figure at $9.1 million, down 40.02% from the prior year.
• Invested Capital was $9.1 million for Q4 2022 at Nephros, down from $9.7 million in the prior quarter.
• The five-year high for Invested Capital was $16.3 million in Q4 2020, with the low at $3.1 million in Q1 2018.
• Average Invested Capital over 5 years is $11.0 million, with a median of $11.0 million recorded in 2020.
• The sharpest annual moves came in 2018 and 2022: Invested Capital jumped 334.29% in 2018, then sank 40.02% in 2022.
• Over 5 years, Invested Capital stood at $8.6 million in 2018, then increased by 2.66% to $8.9 million in 2019, then jumped by 83.75% to $16.3 million in 2020, then decreased by 7.32% to $15.1 million in 2021, then tumbled by 40.02% to $9.1 million in 2022.
• The last three Invested Capital figures came in at $9.1 million (Q4 2022), $9.7 million (Q3 2022), and $12.9 million (Q2 2022), per Business Quant data.